TN2014000211A1 - Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases - Google Patents

Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases

Info

Publication number
TN2014000211A1
TN2014000211A1 TNP2014000211A TN2014000211A TN2014000211A1 TN 2014000211 A1 TN2014000211 A1 TN 2014000211A1 TN P2014000211 A TNP2014000211 A TN P2014000211A TN 2014000211 A TN2014000211 A TN 2014000211A TN 2014000211 A1 TN2014000211 A1 TN 2014000211A1
Authority
TN
Tunisia
Prior art keywords
ttr
rnai agents
methods
associated diseases
compositions
Prior art date
Application number
TNP2014000211A
Inventor
Kallanthottathil G Rajeev
Tracy Zimmermann
Muthiah Manoharan
Martin Maier
Satyanarayana Kuchimanchi
Klaus Charisse
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/065691 external-priority patent/WO2013075035A1/en
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Publication of TN2014000211A1 publication Critical patent/TN2014000211A1/en

Links

Abstract

The present invention provides RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene and methods of using such RNAi agents for treating or preventing TTR- associated diseases.
TNP2014000211A 2012-08-06 2014-05-14 Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases TN2014000211A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261680098P 2012-08-06 2012-08-06
PCT/US2012/065691 WO2013075035A1 (en) 2011-11-18 2012-11-16 Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases

Publications (1)

Publication Number Publication Date
TN2014000211A1 true TN2014000211A1 (en) 2015-09-30

Family

ID=59799102

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000211A TN2014000211A1 (en) 2012-08-06 2014-05-14 Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases

Country Status (1)

Country Link
TN (1) TN2014000211A1 (en)

Similar Documents

Publication Publication Date Title
PH12014501106A1 (en) Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases
MY195720A (en) Transthyretin (Ttr) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-Associated Diseases
WO2015042564A8 (en) Methods for treating or preventing transthyretin (ttr) associated diseases
PH12019550076A1 (en) SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
TR201820333T4 (en) Compositions Containing Bacterial Strains
EA201891200A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MX2021006053A (en) Angiotensinogen (agt) irna compositions and methods of use thereof.
MD3204025T2 (en) Compositions comprising bacterial strains
MX2018006217A (en) Apelin receptor agonists and methods of use.
JO3558B1 (en) Compositions And Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
MX2018008105A (en) Metalloenzyme inhibitor compounds.
EA201490029A1 (en) METALLIC ENZYME INHIBITING COMPOUNDS
MY181888A (en) Tmprss6 irna compositions and methods of use thereof
MY176712A (en) Serpina1 irna compositions and methods of use thereof
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
MX2018016057A (en) Compositions and methods for treating cardiovascular disease.
MX363846B (en) Oligonucleotide modulators of b-cell cll/lymphoma 11a (bcl11a) and uses thereof.
MX2021010716A (en) Compositions and methods for inhibiting expression of the lect2 gene.
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
WO2013120022A3 (en) Treatment of hypoglycemia
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
PH12017501864A1 (en) Compositions and methods for treating autism
MX2015006337A (en) Methods and compositions for treating neurodegenerative diseases.
MX2021006326A (en) Pcna inhibitors.
MX2013014488A (en) Methods and compositions for treating brain cancer.